POSITION SUMMARY (Full Time; Austin, TX):
As a Pathologist, you have clinical oversight of Natera’s laboratory testing. You ensure that testing is properly performed, and applicable regulatory standards are met. You are responsible for ensuring that the laboratory implements testing while consistently providing accurate and reliable patient test results. You will be responsible for histopathologic evaluation of tissue samples for testing suitability.
PRIMARY RESPONSIBILITIES:
- Review patient specimens prior to testing in collaboration with other applicable stakeholders.
- Review clinical notes (e.g., chief complaint and treatment history) and pathology reports for tumor information (primary location, histologic type and sample location [primary vs metastatic]) and perform tumor circling on H&E slides for molecular testing; and help to identify an alternative optimal FFPE block(s) and/or tumor specimen if the current sample is inadequate.
- Review, approve, and sign-out reports for oncology testing, mainly on NGS platforms.
- Provide clinical and technical support for genetic counselors and other laboratory personnel. Set standards for laboratory testing and acceptable levels of analytic performance and ensure these are maintained.
- Analyze lab data, contribute to or write publications for high-quality scientific journals.
- May serve as Clinical Consultant. The Clinical Consultant is responsible for ensuring:
- the proper utility of our assays including sample selection, and test appropriateness,
- test reports include pertinent information for test interpretation, and
- availability for consultation concerning test results and the interpretation of those results as they relate to specific patient conditions.
- May manage a team. Review and approve assigned work; mentor and develop personnel, including dedicated succession planning and contingency management.
- This role works with PHI on a regular basis both in paper and electronic form and has access to various technologies to access PHI (paper and electronic) in order to perform the job.
- Employee must complete training relating to HIPAA/PHI privacy, General Policies and Procedure Compliance training and security training as soon as possible but not later than the first 30 days of hire.
- Must maintain a current status on Natera training requirements.
- Employee must pass a post-offer criminal background check.
QUALIFICATIONS:
- MD/DO degree and ABP board-certified/eligible in AP required. Board certification/eligible for Molecular Genetic Pathology is preferred, but not required.
- Qualified for an unrestricted Medical License to practice in the states of Texas and California (current status is not required but must obtain licenses at the start of employment).
- Certificate of Qualification in Histopathology from the NYS CLEP required (current status preferred, but may obtain after hire if applicant meets qualifications). Certificate of Qualification in Oncology, Molecular and Cellular Tumor Markers from the NYS CLEP or meeting qualifications for application is preferred.
- All levels of experience will be considered. Experience in a CLIA-certified clinical laboratory setting analyzing, interpreting and reporting clinical genetic/genomic data and/or MGP Fellowship graduates are preferred.
- Knowledge of CAP, CLIA, California, and New York state regulations.
KNOWLEDGE, SKILLS, AND ABILITIES:
- Excellent written and oral communication skills.
- Histopathologic evaluation of tissue specimens for molecular diagnostic testing.
- Knowledge of preanalytical factors affecting next-generation sequencing performance.
- Knowledge and experience of histology laboratory regulatory requirements and procedures.
- Familiarity with next-generation sequencing.
- Understanding of statistical measures utilized in genomic testing.
PHYSICAL DEMANDS & WORK ENVIRONMENT:
- Duties typically performed in BSL-2 lab setting.
- Standing or sitting for long periods of time may be necessary.
- Duties may require working various shifts, weekends, and/or overtime.
Travel required for this position:
No ☐ or Yes ☒ : If yes state anticipated percent for travel: up to 10%
